Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Helius Medical Technologies, Inc. (HSDT)

0.2993
+0.0076
+(2.61%)
At close: April 28 at 4:00:03 PM EDT
Loading Chart for HSDT
  • Previous Close 0.2917
  • Open 0.3100
  • Bid --
  • Ask --
  • Day's Range 0.2854 - 0.3100
  • 52 Week Range 0.2600 - 4.2000
  • Volume 73,745
  • Avg. Volume 134,586
  • Market Cap (intraday) 1.834M
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) --
  • EPS (TTM) -4.3300
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

heliusmedical.com

21

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HSDT

View More

Performance Overview: HSDT

Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HSDT
55.33%
S&P 500 (^GSPC)
6.00%

1-Year Return

HSDT
93.35%
S&P 500 (^GSPC)
8.41%

3-Year Return

HSDT
99.79%
S&P 500 (^GSPC)
28.95%

5-Year Return

HSDT
99.96%
S&P 500 (^GSPC)
93.08%

Compare To: HSDT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HSDT

View More

Valuation Measures

Annual
As of 4/28/2025
  • Market Cap

    1.83M

  • Enterprise Value

    757.74k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.56

  • Price/Book (mrq)

    1.73

  • Enterprise Value/Revenue

    1.46

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -154.25%

  • Return on Equity (ttm)

    -688.88%

  • Revenue (ttm)

    520k

  • Net Income Avi to Common (ttm)

    -11.74M

  • Diluted EPS (ttm)

    -4.3300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.09M

  • Total Debt/Equity (mrq)

    1.13%

  • Levered Free Cash Flow (ttm)

    -5.86M

Research Analysis: HSDT

View More

Company Insights: HSDT

Research Reports: HSDT

View More

People Also Watch